ReportsnReports

Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance

 

Dallas, TX -- (ReleaseWire) -- 09/18/2012 -- “Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance” - provides an overview of the most exciting innovations in drug delivery technologies in major therapeutic areas – oncology, vaccines, diabetes, rheumatology and respiratory diseases. Each chapter highlights emerging companies with technologies that have the potential to transform drug delivery in that specific therapeutic area. The report also explores the current environment in healthcare and the pharmaceutical industry, and examines drivers and challenges for the use of innovative drug delivery technologies.

Drug delivery technologies provide commercial opportunities for pharmaceutical companies by improving the chances of success for a drug development project. They enable the formulation of a promising molecule that might have poor solubility or require selective delivery to a particular tissue, such as the brain. Similarly, drug delivery technologies may enable companies to differentiate products within crowded therapeutic areas, facilitate life cycle management for existing drugs, and reposition existing drugs – proprietary or generic – in new indications where the needs of the patient population are different or, again, where more targeted delivery is required. Products that are reformulated with novel drug delivery systems do not meet the traditional criteria for innovative products – in other words, products that include new active moieties. Nevertheless, GBI Research’s analysis shows that the commercial success of existing products that rely on innovative drug delivery technologies is clear, and these products make significant positive changes for patients.

Scope
- Detailed analysis of the reasons for the industry to look closely at drug delivery technologies.
- Exploration of the environment in healthcare and the pharmaceutical industry that is driving companies to invest in drug delivery.
- Insight into collaborations between the largest pharmaceutical companies and smaller companies with innovative drug delivery technologies.
- Detailed insight into innovation in drug delivery in key therapeutic areas: oncology, vaccines, diabetes, rheumatology and respiratory diseases.
- Case studies of leading companies, their technologies and clinical data emerging from important drug development programs.

Reasons to buy
- Identify leading drug delivery companies.
- Learn about mergers, acquisitions and collaborations in drug delivery.
- Develop strategies and priorities for investing in drug delivery technologies.
- Understand the most important technologies and companies involved in developing new drug delivery technologies in key therapeutic areas.
- Explore the needs of patients in each therapeutic area and the ways in which drug delivery technologies can be used to meet these within drug development pipelines.

Buy your copy of this report @ http://www.reportsnreports.com/reports/192515-innovations-in-drug-delivery-broad-based-proprietary-technology-platforms-to-address-delivery-efficiency-and-improve-patient-compliance.html .

List of Tables

Table 1: Innovation in Drug Delivery, Blockbuster Products Including Drug Delivery Systems, 2012
Table 2: Innovation in Drug Delivery, Examples of Leading Drug Delivery Companies, 2012
Table 3: Innovation in Drug Delivery, Examples of Licensing Deals for Drug Delivery, 2012
Table 4: Innovation in Drug Delivery, Examples of Licensing Deals for Drug Delivery, 2012
Table 5: Innovation in Drug Delivery, Examples of Oncology Drugs in Clinical Development with Drug Delivery Systems (by Technology Platform), 2012
Table 6: Innovation in Drug Delivery, Advances in PEGylation Technologies, 2012
Table 7: Innovation in Drug Delivery, Examples of Nanoparticulate Drug Delivery Systems, 2012
Table 8: Innovation in Drug Delivery, Approved Cancer Drugs with Liposomal Delivery Systems, 2012
Table 9: Innovation in Drug Delivery, Companies Developing Viral Vector Delivery Systems for Vaccines, 2012
Table 10: Innovation in Drug Delivery, Companies Developing Intranasal Vaccines and their Technologies, 2012
Table 11: Innovation in Drug Delivery, Companies Developing Oral Vaccines and their Technologies, 2012
Table 12: Innovation in Drug Delivery, Companies Developing Transdermal Vaccines and their Technologies, 2012
Table 13: Innovation in Drug Delivery, Inhaled Insulin Products and their Development Status, 2012
Table 14: Innovation in Drug Delivery, Oral Insulin Products and their Development Status, 2012
Table 15: Innovation in Drug Delivery, GLP-1 Analogs and their Development Status, 2012
Table 16: Innovation in Drug Delivery, Leading Drugs for Arthritis and their Delivery Systems, 2012
Table 17: Innovation in Drug Delivery, Leading Autoinjector Manufacturers and their Products, 2012
Table 18: Innovation in Drug Delivery, Examples of Liquid Jet Injectors for Needle Free Delivery, 2012 53
Table 19: Innovation in Drug Delivery, Companies Commercializing Aerosol Drug Delivery Technologies, 2012
Table 20: Innovation in Drug Delivery, Drug Delivery Requirements in Different Therapeutic Areas, 2012

List of Figures

Figure 1: Innovation in Drug Delivery, Commonly Used Options for Drug Delivery, 2012
Figure 2: Innovation in Drug Delivery, Uses of Drug Delivery Technology, 2012
Figure 3: Innovation in Drug Delivery, Commercial Opportunities for Drug Delivery Systems, 2012
Figure 4: Innovation in Drug Delivery, Reducing Drug Toxicity Through Drug Delivery, 2012

Contact sales@reportsandreports.com for further information.